(MENAFN- EIN Presswire) EINPresswire/ -- The global single-use bioreactors market is projected to be valued at US$ 4.2 billion in 2026 and is forecast to reach US$ 8.5 billion by 2033, expanding at a ...

The "Single Use Bioreactors Market Industry Trends and Global Forecasts to 2035, by Type of Bioreactor, Scale of Operation, Type of Cell Culture, Type of Biologics Synthesized, Application Area, ...

The "Single-use Technologies for Biopharmaceuticals Market" report has been added to ResearchAndMarkets.com's offering. The Single-use Technologies for Biopharmaceuticals was valued at USD 6.5 billion ...

WuXi Biologics, a CRDMO, reports that three sets of 5,000L single-use bioreactors have been installed in the second drug substance line at its drug substance manufacturing facility in Hangzhou (MFG20) ...

Sartorius AG is a pure play in the bioprocessing industry, dominating the single-use bioreactors market with a focus on upstream flow. Sartorius' strong customer relationships and service-first ...

CDMO’s new site introducing the most advanced and large-scale single-use bioreactors in the region According to 2024 data from BDO Group's bioTRAK Database, single-use technology represents 51 percent ...

WuXi Biologics ("WuXi Bio"), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the successful completion of the first commercial project Process ...

The university plays a vital role in addressing social challenges and improving quality of life. Its success is built on five dynamic institutes specializing in chemistry and biotechnology, food and ...